Łukasz Sobczak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Łukasz Sobczak has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Agata Wszołek
Institute of Biology, University of Szczecin, Felczaka 3c St., 70-453 Szczecin, Poland
1 shared publication - Agnieszka Maruszewska
Institute of Biology, University of Szczecin, Wąska 13, 71-415 Szczecin, Poland
1 shared publication - Anna Nowakowska
Institute of Biology, University of Szczecin, Felczaka 3c St., 70-453 Szczecin, Poland
1 shared publication - Dominika Ciosek
Institute of Biology, University of Szczecin, Felczaka 3c St., 70-453 Szczecin, Poland
1 shared publication - Edyta Stępień
Institute of Marine and Environmental Sciences, University of Szczecin, Adama Mickiewicza 16 St., 70-383 Szczecin, Poland
1 shared publication - Izabela Gutowska
Department of Medical Chemistry, Pomeranian Medical University, 70-204 Szczecin, Poland
1 shared publication
Latest Publications
- Open Access
- 10 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1551
Preliminary Assessment of Anticancer Activity of Aqueous Meadowsweet (Filipendula ulmaria (L.) Maxim.) Extract in LoVo Colorectal Cancer Cells
Background/Objectives: Filipendula ulmaria (L.) Maxim. (meadowsweet) is a medicinal plant traditionally used for its antioxidant and anti-inflammatory effects. There is also some data indicating its anticancer potential; however, its impact on colorectal cancer cells remains poorly understood. Here we investigated the cytotoxic and pro-apoptotic effects of an aqueous F. ulmaria extract on human LoVo colorectal cancer cells and analyzed some of the mechanisms underlying it. Methods: LoVo colorectal cancer cells were treated with the aqueous extract and analyzed for intracellular reactive oxygen species (ROS), mitochondrial membrane potential, DNA damage, lysosomal alterations, apoptosis-related mechanisms, and antioxidant activity. Phytochemical profiling was performed by HPLC-TOF/MS. Results: The extract elevated intracellular ROS levels, disrupted mitochondrial membrane potential, and induced DNA damage in LoVo cells. Activation of crucial caspases, along with increased p53 levels, confirmed engagement of both extrinsic and intrinsic apoptotic pathways. Changes in lysosomal fluorescence were also observed, indicating alterations in lysosomal properties. In chemical assays (FRAP, TAC, DPPH, ABTS, and superoxide scavenging), the extract demonstrated robust antioxidant capacity comparable to or exceeding that of ascorbic acid. Phytochemical profiling by HPLC-TOF/MS revealed a rich presence of bioactive flavonoids, phenolic acids, and coumarins. Altogether, our findings indicate that the extract’s cytotoxicity against colon cancer cells arises from a multifaceted mechanism involving oxidative stress, organelle dysfunction, and apoptosis induction. Conclusions: These results highlight F. ulmaria aqueous extract as a promising candidate for colorectal cancer phytotherapy as a form of supportive treatment and warrant further preclinical validation.
- 10 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1551
Open AccessPreliminary Assessment of Anticancer Activity of Aqueous Meadowsweet (Filipendula ulmaria (L.) Maxim.) Extract in LoVo Colorectal Cancer Cells
Background/Objectives: Filipendula ulmaria (L.) Maxim. (meadowsweet) is a medicinal plant traditionally used for its antioxidant and anti-inflammatory effects. There is also some data indicating its anticancer potential; however, its impact on colorectal cancer cells remains poorly understood. Here we investigated the cytotoxic and pro-apoptotic effects of an aqueous F. ulmaria extract on human LoVo colorectal cancer cells and analyzed some of the mechanisms underlying it. Methods: LoVo colorectal cancer cells were treated with the aqueous extract and analyzed for intracellular reactive oxygen species (ROS), mitochondrial membrane potential, DNA damage, lysosomal alterations, apoptosis-related mechanisms, and antioxidant activity. Phytochemical profiling was performed by HPLC-TOF/MS. Results: The extract elevated intracellular ROS levels, disrupted mitochondrial membrane potential, and induced DNA damage in LoVo cells. Activation of crucial caspases, along with increased p53 levels, confirmed engagement of both extrinsic and intrinsic apoptotic pathways. Changes in lysosomal fluorescence were also observed, indicating alterations in lysosomal properties. In chemical assays (FRAP, TAC, DPPH, ABTS, and superoxide scavenging), the extract demonstrated robust antioxidant capacity comparable to or exceeding that of ascorbic acid. Phytochemical profiling by HPLC-TOF/MS revealed a rich presence of bioactive flavonoids, phenolic acids, and coumarins. Altogether, our findings indicate that the extract’s cytotoxicity against colon cancer cells arises from a multifaceted mechanism involving oxidative stress, organelle dysfunction, and apoptosis induction. Conclusions: These results highlight F. ulmaria aqueous extract as a promising candidate for colorectal cancer phytotherapy as a form of supportive treatment and warrant further preclinical validation.